.Pharmacolibrary.Drugs.ATC.N.N03AG01 .Pharmacolibrary.Drugs.ATC.N.N03AG01| name: | ValproicAcid |
| ATC code: | N03AG01 | route: | oral |
| n-compartments | 1 |
Valproic acid is an antiepileptic drug (AED) used primarily for the treatment of epilepsy, bipolar disorder, and prevention of migraine headaches. It is a broad-spectrum anticonvulsant approved for use in many countries, including the US and EU.
Pharmacokinetic model parameters observed in healthy adult volunteers aged 18-55, both male and female, following a single oral dose.
Wang, WJ, et al., & Chen, F (2024). Population pharmacokinetics of valproic acid in children with epilepsy: Implications for dose tailoring when switching from oral syrup to sustained-release tablets. CPT: pharmacometrics & systems pharmacology 13(9) 1554–1569. DOI:10.1002/psp4.13191 PUBMED:https://pubmed.ncbi.nlm.nih.gov/38923247
Xu, S, et al., & Zhao, L (2018). Population pharmacokinetics of valproic acid in epileptic children: Effects of clinical and genetic factors. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 122 170–178. DOI:10.1016/j.ejps.2018.06.033 PUBMED:https://pubmed.ncbi.nlm.nih.gov/29981400
Xu, S, et al., & Zhao, L (2018). Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling. European journal of clinical pharmacology 74(5) 583–591. DOI:10.1007/s00228-018-2414-8 PUBMED:https://pubmed.ncbi.nlm.nih.gov/29340733